Description
Identification of therapeutically relevant gene mutations for Cancer
500 gene and KRAS/NRAS/BRAF Mutation
Identification of therapeutically relevant gene mutations for Cancer
TAT:
Specimen Type:
Genomics Single Test
Other Tests
-
264%
OncQuer TM Scout LB EGFR Response Test
Identification gene mutations leading to sensitivity and resistance to EGFR therapy
OncQuer TM Scout LB EGFR Response Test
Identification gene mutations leading to sensitivity and resistance to EGFR therapy
-
249%
Endopredict
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
-
264%
ONCQUER(TM) AML COMBO PANEL
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
ONCQUER(TM) AML COMBO PANEL
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
-
255%
GERMLINE BRCA 1 AND 2 – LAL PATH LAB
Panel of BRCA1&2 Genes
Reviews
There are no reviews yet.